Patents by Inventor Devon Jensen

Devon Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230348975
    Abstract: Disclosed herein include systems, methods, compositions, and kits for determining protein expression and gene expression simultaneously and for sample indexing. In some embodiments, an oligonucleotide associated with a cellular component-binding reagent (e.g., an antibody) comprises one or more of a unique molecular label sequence, a primer adapter, antibody-specific barcode sequence, an alignment sequence, and/or a poly(A) sequence. In some embodiments, the oligonucleotide is associated with the cellular component-binding reagent via a linker (e.g., 5AmMC12).
    Type: Application
    Filed: March 21, 2023
    Publication date: November 2, 2023
    Inventors: Eleen Shum, Katherine Lazaruk, Dennis E. Prosen, Devon Jensen, David Rosenfeld, Janice H. Lai, James Ghadiali, Christina Chang
  • Publication number: 20230272454
    Abstract: Disclosed herein include systems, methods, compositions, and kits for immune repertoire profiling. There are provided, in some embodiments, primer panels enabling the determination of the nucleotide sequence of the complete variable region of nucleic acids encoding mouse B cell receptor (BCR) and T cell receptor (TCR) polypeptides. In some embodiments, the method comprises single cell transcriptomic analysis.
    Type: Application
    Filed: March 27, 2023
    Publication date: August 31, 2023
    Inventors: Devon Jensen, Katherine Lazaruk, Dennis Prosen, Ricelle A. Acob, Kai Liu
  • Patent number: 11661625
    Abstract: Disclosed herein include systems, methods, compositions, and kits for immune repertoire profiling. There are provided, in some embodiments, primer panels enabling the determination of the nucleotide sequence of the complete variable region of nucleic acids encoding mouse B cell receptor (BCR) and T cell receptor (TCR) polypeptides. In some embodiments, the method comprises single cell transcriptomic analysis.
    Type: Grant
    Filed: May 13, 2021
    Date of Patent: May 30, 2023
    Assignee: Becton, Dickinson and Company
    Inventors: Devon Jensen, Katherine Lazaruk, Dennis Prosen, Ricelle A. Acob, Kai Liu
  • Patent number: 11661631
    Abstract: Disclosed herein include systems, methods, compositions, and kits for determining protein expression and gene expression simultaneously and for sample indexing. In some embodiments, an oligonucleotide associated with a cellular component-binding reagent (e.g., an antibody) comprises one or more of a unique molecular label sequence, a primer adapter, antibody-specific barcode sequence, an alignment sequence, and/or a poly(A) sequence. In some embodiments, the oligonucleotide is associated with the cellular component-binding reagent via a linker (e.g., 5AmMC12).
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: May 30, 2023
    Assignee: Becton, Dickinson and Company
    Inventors: Eleen Shum, Katherine Lazaruk, Dennis E. Prosen, Devon Jensen, David Rosenfeld, Janice H. Lai, James Ghadiali, Christina Chang
  • Publication number: 20210355484
    Abstract: Disclosed herein include systems, methods, compositions, and kits for immune repertoire profiling. There are provided, in some embodiments, primer panels enabling the determination of the nucleotide sequence of the complete variable region of nucleic acids encoding mouse B cell receptor (BCR) and T cell receptor (TCR) polypeptides. In some embodiments, the method comprises single cell transcriptomic analysis.
    Type: Application
    Filed: May 13, 2021
    Publication date: November 18, 2021
    Inventors: Devon Jensen, Katherine Lazaruk, Dennis Prosen, Ricelle A. Acob, Kai Liu
  • Publication number: 20200255888
    Abstract: Disclosed herein include systems, methods, compositions, and kits for determining numbers of occurrences of variants (e.g., transcript variants) of targets (e.g., gene targets) in cells and/or samples. In some embodiments, modification target sites (e.g., polyadenylation sites) and usage thereof are determined. Whole transcriptome amplification analysis can be performed and the sequencing reads obtained can be analyzed to identify polyadenylation sites (and usage thereof) for the design of customized primer panels for targeted scRNAseq experiments.
    Type: Application
    Filed: February 11, 2020
    Publication date: August 13, 2020
    Inventors: Devon Jensen, David Rosenfeld, Christina Fan, Jue Fan
  • Publication number: 20200232032
    Abstract: Disclosed herein include systems, methods, compositions, and kits for determining protein expression and gene expression simultaneously and for sample indexing. In some embodiments, an oligonucleotide associated with a cellular component-binding reagent (e.g., an antibody) comprises one or more of a unique molecular label sequence, a primer adapter, antibody-specific barcode sequence, an alignment sequence, and/or a poly(A) sequence. In some embodiments, the oligonucleotide is associated with the cellular component-binding reagent via a linker (e.g., 5AmMC12).
    Type: Application
    Filed: January 21, 2020
    Publication date: July 23, 2020
    Inventors: Eleen Shum, Katherine Lazaruk, Dennis E. Prosen, Devon Jensen, David Rosenfeld, Janice H. Lai, James Ghadiali, Christina Chang